| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| WASSON GREGORY D | Director | C/O P3 HEALTH PARTNERS INC., 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON | /s/Todd Smith, Chief Legal Officer, as attorney-in-fact | 23 Jan 2026 | 0001188827 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PIII | Class A Common Stock | Award | $0 | +2,000 | +46% | $0.000000 | 6,331 | 06 Aug 2025 | Direct | F1, F2 |
| holding | PIII | Class A Common Stock | 17,192 | 06 Aug 2025 | G&K Investment Holdings LLC | F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest upon the earlier of the Company's 2026 annual stockholder meeting and the one-year anniversary of the grant date. |
| F2 | This amended Form 4 is being filed to correct Column 5 of Table I, which inadvertently reported the number of securities beneficially owned by the Reporting Person prior to the Company's 1-for-50 reverse stock split, which became effective on April 11, 2025, and excluded certain securities indirectly owned by the Reporting Person. This amended Form 4 is being filed to correct the number of securities beneficially owned by the Reporting Person to reflect the reverse stock split, as well as the Reporting Person's indirect ownership. |
| F3 | The Reporting Person has voting and dispositive power over the securities held by G&K Investment Holdings LLC. |